2 studies found for:    CA220-007
Show Display Options
Rank Status Study
1 Completed Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma
Condition: Melanoma
Interventions: Biological: BMS-982470 (recombinant interleukin-21);   Biological: Ipilimumab
2 Recruiting Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin
Condition: Lung Cancer - Non Small Cell
Interventions: Drug: Ipilimumab;   Drug: Placebo;   Drug: Paclitaxel;   Drug: Carboplatin

Indicates status has not been verified in more than two years